Discovery & Development

Exploring a new approach to treating IBS pain.

In what ways can the microbiome interact with oral medicines?

Why drug developers should take a fresh look at long-acting dosage forms.

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

Can we trust the integrity of clinical trials?

One analytical technique that is seeing increasing popularity, in part due to its precision and reproducibility, is capillary electrophoresis.

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies.

Acetaminophen derivatives could offer patients a safer alternative to common pain management treatments.

How can companies be encouraged to develop treatments for the growing number of patients living with CNS disorders?

Harnessing the potential of microphysiological systems to advance drug discovery.